Home/Filings/4/0001562180-24-004944
4//SEC Filing

McShane Geri-Michelle 4

Accession 0001562180-24-004944

CIK 0001524472other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 4:18 PM ET

Size

15.8 KB

Accession

0001562180-24-004944

Insider Transaction Report

Form 4
Period: 2024-06-10
McShane Geri-Michelle
VP, Controller & CAO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-06-10$75.18/sh+1,019$76,6085,067 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2024-06-101,0191,019 total
    Exercise: $75.18Exp: 2028-02-21Common Stock (1,019 underlying)
  • Sale

    Common Stock

    2024-06-10$138.63/sh2,278$315,7993,536 total
  • Exercise/Conversion

    Common Stock

    2024-06-10$74.07/sh+747$55,3305,814 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2024-06-10747747 total
    Exercise: $74.07Exp: 2029-02-20Common Stock (747 underlying)
Footnotes (3)
  • [F1]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,278 Shares were executed at a range of prices from $138.62 to $138.65. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  • [F2]The February 21, 2018 option grant vested one third on February 21, 2019, February 21, 2020, and February 21, 2021.
  • [F3]The February 20, 2019 option grant vested one third on February 20, 2020, February 20, 2021, and February 20, 2022.

Issuer

Xylem Inc.

CIK 0001524472

Entity typeother

Related Parties

1
  • filerCIK 0001769064

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:18 PM ET
Size
15.8 KB